- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03324204
Shock Wave Therapy Versus Neuromuscular Training in Women With Patellofemoral Pain
October 24, 2017 updated by: Piotr Michalik, Medical University of Silesia
The aim of the trial is to compare the efficacy of extracorporeal shock wave therapy (ESWT) versus neuromuscular training (TR) in reducing pain in women with patellofemoral pain (PFP).
Women with PFP will be randomly divided into two therapeutic groups: ESWT and TR.
The ESWT group will undergo extracorporeal shock wave therapy to the iliotibial band and tensor fascia latae.
The TR group will be treated with neuromuscular training.
The women's gait will be analysed and the strength of hip abductors and internal rotators will be measured.
Additionally, the women's pain and health status will be assessed with the visual analogue scale and the Lysholm Scale.
Outcomes will be registered at baseline, and then at five weeks and at three months post-therapy
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Śląskie
-
Katowice, Śląskie, Poland, 40-752
- Recruiting
- Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Knee pain for more than three months greater than three on the visual analogue scale (VAS) during at least two out of four typical activities:
- ascending or descending the stairs,
- prolonged sitting with flexed knee,
- running or jumping,
- squatting or kneeling.
Exclusion Criteria:
- Orthopaedic diagnosis other than PFP.
- Patients with neurological disorders, history of injury or operations within the symptomatic leg, rheumatoid disease, or pregnancy were also excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Neuromuscular Training
Each session lasted 30 minutes and consisted of three sets of exercises with 20-30 repetitions.
Emphasis is placed on proper knee alignment during exercise.
Most of the women exhibit excessive medial rotation and adduction of the femur, resulting in knee valgus.
The women will be instructed how to correct their abnormalities using mirrors as visual feedback.
All exercises will be completed without pain.
If the exercises are too easy, the level of difficulty will be increased individually in accordance with the rehabilitation protocol
|
Each session lasted 30 minutes and consisted of three sets of exercises with 20-30 repetitions.
Emphasis was placed on proper knee alignment during exercise.
Most of the women exhibited excessive medial rotation and adduction of the femur, resulting in knee valgus, although knee varus was also observed.
The women were instructed how to correct their abnormalities using mirrors as visual feedback.
All exercises were completed without pain.
If the exercises were too easy, the level of difficulty was increased individually in accordance with the rehabilitation protocol
|
|
Active Comparator: Shock Wave Therapy
The ESWT group will will meet the therapist twice in the first week, and once a week after it.
ESWT will be applied to the iliotibial band and tensor fascia latae with the following parameters: pressure - 4.5 bar, emission frequency -8 Hz, number of pulses per dose -2,500 per session.
|
ESWT will be applied to the iliotibial band and tensor fascia latae muscle with the following parameters: pressure - 4.5 bar, emission frequency -8 Hz, number of pulses per dose -2,500 per session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale is used to assess the subjective Pain.
Time Frame: Outcome measures are obtained at baseline (pre-intervention)
|
The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)
|
Outcome measures are obtained at baseline (pre-intervention)
|
|
Visual Analog Scale is used to assess the subjective Pain.
Time Frame: Outcome measures are obtained, at five weeks after intervention.
|
The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)
|
Outcome measures are obtained, at five weeks after intervention.
|
|
Visual Analog Scale is used to assess the subjective Pain.
Time Frame: Outcome measures are obtained at three months after intervention
|
The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)
|
Outcome measures are obtained at three months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.
Time Frame: Outcome measures are obtained at baseline (pre-intervention)
|
The women walk on the treadmill barefoot for three minutes in order to become accustomed to the speed belt.
After that time, the angles of the joints are measured for 30 seconds.
Internal rotation is demarcated at the highest peak in midstance when the contralateral limb is in the terminal stance (toe-off phase).
Hip adduction is determined at the highest peak in midstance
|
Outcome measures are obtained at baseline (pre-intervention)
|
|
Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.
Time Frame: Outcome measures are obtained, at five weeks after intervention.
|
The women walk on the treadmill barefoot for three minutes in order to become accustomed to the speed belt.
After that time, the angles of the joints are measured for 30 seconds.
Internal rotation is demarcated at the highest peak in midstance when the contralateral limb is in the terminal stance (toe-off phase).
Hip adduction is determined at the highest peak in midstance
|
Outcome measures are obtained, at five weeks after intervention.
|
|
Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.
Time Frame: Outcome measures are obtained at three months after intervention
|
The women walk on the treadmill barefoot for three minutes in order to become accustomed to the speed belt.
After that time, the angles of the joints are measured for 30 seconds.
Internal rotation is demarcated at the highest peak in midstance when the contralateral limb is in the terminal stance (toe-off phase).
Hip adduction is determined at the highest peak in midstance
|
Outcome measures are obtained at three months after intervention
|
|
Muscle strength is tested using the Micro Fet Handheld Dynamometer.
Time Frame: Outcome measures are obtained at baseline (pre-intervention)
|
Muscle strength of lateral rotators, abductors of the hip is tested.
Three repetitions of muscle strength testing are performed with two 30-second intervals.
The participants a of re asked to press against the Dynamometer with the maximum effort for 5-7 seconds.
|
Outcome measures are obtained at baseline (pre-intervention)
|
|
Muscle strength is tested using the Micro Fet Handheld Dynamometer.
Time Frame: Outcome measures are obtained, at five weeks after intervention.
|
Muscle strength of lateral rotators, abductors of the hip is tested.
Three repetitions of muscle strength testing are performed with two 30-second intervals.
The participants a of re asked to press against the Dynamometer with the maximum effort for 5-7 seconds.
|
Outcome measures are obtained, at five weeks after intervention.
|
|
Muscle strength is tested using the Micro Fet Handheld Dynamometer.
Time Frame: Outcome measures are obtained at three months after intervention
|
Muscle strength of lateral rotators, abductors of the hip is tested.
Three repetitions of muscle strength testing are performed with two 30-second intervals.
The participants a of re asked to press against the Dynamometer with the maximum effort for 5-7 seconds.
|
Outcome measures are obtained at three months after intervention
|
|
The self-reported health status is measured using the Lysholm Questionaire (LQ)
Time Frame: Outcome measures are obtained at baseline (pre-intervention)
|
The participants are asked to complete the eight-item questionnaire, scored on a 0-100 weighted scale
|
Outcome measures are obtained at baseline (pre-intervention)
|
|
The self-reported health status is measured using the Lysholm Questionaire (LQ)
Time Frame: Outcome measures are obtained, at five weeks after intervention.
|
The participants are asked to complete the eight-item questionnaire, scored on a 0-100 weighted scale
|
Outcome measures are obtained, at five weeks after intervention.
|
|
The self-reported health status is measured using the Lysholm Questionaire (LQ)
Time Frame: Outcome measures are obtained at three months after intervention
|
The participants are asked to complete the eight-item questionnaire, scored on a 0-100 weighted scale
|
Outcome measures are obtained at three months after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Mgdalena Dabrowska-Galas, PhD, Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2014
Primary Completion (Anticipated)
June 1, 2018
Study Completion (Anticipated)
January 1, 2019
Study Registration Dates
First Submitted
July 18, 2017
First Submitted That Met QC Criteria
October 24, 2017
First Posted (Actual)
October 27, 2017
Study Record Updates
Last Update Posted (Actual)
October 27, 2017
Last Update Submitted That Met QC Criteria
October 24, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- kolanostudentki
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
The datasets used and/or analysed during the current study will be available from the corresponding author on reasonable request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patellofemoral Pain Syndrome
-
University of North Carolina, Chapel HillCanadian Institutes of Health Research (CIHR)CompletedPatellofemoral Pain Syndrome | Patellofemoral Pain (PFPS) | Patellofemoral Pain | Patellofemoral Pain, PFPUnited States
-
Lauren EricksonAmerican College of Sports MedicineCompleted
-
Beijing Sport UniversityCompletedPatellofemoral PainChina
-
Boston Children's HospitalEnrolling by invitationPatellofemoral PainUnited States
-
Pamukkale UniversityNot yet recruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Ahram Canadian UniversityNot yet recruitingPatellofemoral Pain (PFPS)Egypt
-
Beijing Sport UniversityCompletedPatellofemoral Pain, PFPChina
-
Beijing Sport UniversityNot yet recruitingPatellofemoral Pain, PFP
-
Beijing Sport UniversityNot yet recruiting
-
Istanbul University - CerrahpasaRecruitingPatellofemoral Pain, PFPTurkey (Türkiye)
Clinical Trials on Neuromuscular Training
-
Hospital for Special Surgery, New YorkCompletedHealthy | Neuromuscular Control | Athletic Performance and Injury RiskUnited States
-
Investigación en Hemofilia y FisioterapiaCompleted
-
The University of Hong KongUnknownDevelopmental Coordination DisorderHong Kong
-
Riphah International UniversityCompletedAnterior Cruciate Ligament InjuriesPakistan
-
National Taiwan University HospitalRecruitingElectrical Stimulation | Neuromuscular Control | Multidirectional Instability | Hypermobility Spectrum Disorder | Humeral Head TranslationTaiwan
-
The Methodist Hospital Research InstituteCompleted
-
Acibadem UniversityIstanbul UniversityCompletedBasketball Players | Healthy Young WomenTurkey
-
Schulthess KlinikCompletedSymptomatic Femoroacetabular ImpingementSwitzerland
-
University of ManitobaUnknown